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ABSTRACT
Monoallelic expression within a gene family is
found in pathogens exhibiting antigenic variation
and in mammalian olfactory neurons. Trypanosoma
brucei, a lethal parasite living in the human blood-
stream, expresses variant surface glycoprotein
(VSG) from 1 of 15 bloodstream expression sites
(BESs) by virtue of a multifunctional RNA polymerase
I. The active BES is transcribed in an extranucleolar
compartment termed the expression site body (ESB),
whereas silent BESs, located elsewhere within the
nucleus, are repressed epigenetically. The regulatory
mechanisms, however, are poorly understood. Here
we show that two essential subunits of the basal
class I transcription factor A (CITFA) predominantly
occupied the promoter of the active BES relative to
that of a silent BES, a phenotype that was maintained
after switching BESs in situ. In these experiments,
high promoter occupancy of CITFA was coupled
to high levels of both promoter-proximal RNA
abundance and RNA polymerase I occupancy.
Accordingly, fluorescently tagged CITFA-7 was
concentrated in the nucleolus and the ESB. Because
a ChIP-seq analysis found that along the entire BES,
CITFA-7 is specifically enriched only at the promoter,
our data strongly indicate that monoallelic BES tran-
scription is activated by a mechanism that functions
at the level of transcription initiation.
INTRODUCTION
Monoallelic expression of a large gene family is a phenom-
enon found in parasites that exhibit antigenic variation of
cell surface proteins to evade the mammalian host’s
immune system (1). It also occurs in mammalian olfactory
sensory neurons, which express a single member of the
large odorant receptor (OR) gene family (2). While
monoallelic gene expression of a gene family is typically
regulated at the level of transcription, the mechanisms
enabling transcription of a single gene/allele are not well
understood.
Trypanosoma brucei is a vector-borne lethal parasite in
sub-Saharan Africa that lives freely in the human blood-
stream by virtue of a dense coat of variant surface glyco-
protein (VSG) expressed from a single gene. The uniform
coat shields invariant membrane proteins from immune
recognition (3) and is periodically altered by switching
VSG expression to a different gene. While the parasite
harbors more than 2000 VSG genes and pseudogenes,
VSG expression is restricted to 1 of 15 telomeric blood-
stream expression sites (BESs) (4). A BES is a tandem
array of several expression site-associated genes
(ESAGs) followed by a single VSG gene, all of which
are polycistronically transcribed by a multifunctional
RNA polymerase (pol) I from a promoter that is located
40–60 kb upstream of the VSG gene (5). The active BES
is transcribed outside of the nucleolus (6) in the
extranucleolar expression site body (ESB), a DNase-
resistant compartment that appears to limit productive
transcription to a single BES (7).
Silencing of gene family members is mediated by epi-
genetic mechanisms. Silent OR genes in mice are marked
with histone methylations H3K9me3 and H4K20me3 that
are characteristic of constitutive heterochromatin (8).
Plasmodium falciparum, the parasite causing cerebral
malaria, exhibits monoallelic expression of the var gene
family, which encodes variants of the P. falciparum
erythrocyte membrane protein 1 (9). This protein is
expressed on the surface of an infected erythrocyte and
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mediates cytoadherence to endothelial host receptors
keeping the infected cell in the peripheral vascular
system. Deficiency of the histone deacetylase Sir2 in
P. falciparum led to activation of silent var genes and
loss of monoallelic var gene expression (10,11).
Accordingly, knockdown of T. brucei RAP1, encoding a
telomeric protein known to induce epigenetic gene
silencing, led to derepression of all known BESs, detection
of additional extranucleolar RNA pol I foci and forma-
tion of mixed VSG cell surface coats (12). In addition,
several other factors have been implicated in BES silencing
because their gene knockdowns resulted in derepression
of silent BESs; these comprise the methyltransferase
DOT1B (13), the chromatin remodelers TbISWI (14)
and FACT (15), the histone deacetylase DAC3 (16), the
nucleoplasmin-like protein NLP (17), histone H1 (18),
the origin recognition complex (19), histone H3 and the
histone chaperones CAF-1b and ASF1A (20) as well
as the mini-chromosome maintenance-binding protein
MCM-BP (21). Moreover, nucleosomes are enriched in
the chromatin of silent BESs but are depleted in that of
the active BES (22,23).
While these studies demonstrated the importance of epi-
genetic factors in restricting VSG expression to a single
gene, the mechanism of transcriptional silencing is yet to
be determined. Importantly, in the cited studies, mature
VSG mRNA levels from derepressed BESs remained 10–
10 000-fold lower than that of the active VSG. BES dere-
pression by RAP1 and DOT1B silencing did not affect the
high expression level of the active VSG (12,13), indicating
that derepressed BESs cannot effectively compete with
VSG expression from the active BES. On the other
hand, silencing either SPT16, encoding a FACT subunit,
or NLP did reduce the abundance of active VSG tran-
script (15,17). However, as shown in the NLP study,
promoter-proximal gene expression of the active site was
much less affected, suggesting again that in the dere-
pressed state, BES promoters cannot efficiently compete
for transcription factors from the active promoter.
We have recently characterized the multi-subunit class I
transcription factor A (CITFA) as an essential factor
for RNA pol I transcription of the active BES, the large
ribosomal gene unit (RRNA) and the procyclin gene
units, which encode the major cell surface proteins of
insect-stage, procyclic form (PF) trypanosomes (24).
Characterization of CITFA revealed seven apparently
trypanosomatid-specific proteins, termed CITFA-1 to -7,
and the dynein light chain DYNLL1 (24,25). The purified
complex bound to the 67-bp-long BES promoter in a gel
shift assay requiring the integrity of both known promoter
elements for efficient binding. Moreover, depletion of
CITFA-2 or CITFA-7 from extract or inactivation of
CITFA-2 by an anti-CITFA-2 antibody abolished RNA
pol I transcription in vitro from BES, rRNA gene (RRNA)
and procyclin gene promoters, as determined by 121–146-
bp-long primer extension products. This identified CITFA
as a basal promoter-binding transcription initiation factor
for RNA pol I in trypanosomes (24,25). Accordingly,
silencing of CITFA-2 and of CITFA-7 resulted in rapid
loss of rRNA and mRNA of the active VSG gene in
bloodstream forms (BFs) and in trypanosome death in
culture. Here, anti-CITFA-2 and anti-CITFA-7 chroma-
tin immunoprecipitation (ChIP) assays showed that
CITFA predominantly occupied the active BES
promoter relative to that of a silent BES, a phenotype
maintained after switching BESs in situ. High CITFA oc-
cupancy at the active BES promoter correlated with high
promoter occupancy by RNA pol I and with a high
promoter-proximal RNA level. Accordingly, as shown
for the RRNA loci, CITFA-7 silencing considerably
reduced both promoter-proximal RNA pol I occupancy
and RNA abundance. Together these data strongly
indicate that monoallelic VSG transcription is regulated
at the level of transcription initiation. Moreover,
fluorescently tagged CITFA-7 was found to be
concentrated in the nucleolus and the ESB supporting
the notion that CITFA has a role in BES activation.
Because a ChIP-seq analysis revealed that among BES
sequences high CITFA-7 occupancy is restricted to the
promoter, our results raise the possibility that the
sequestration of CITFA limits productive transcription
initiation by RNA pol I to the nucleolus and the ESB.
MATERIALS AND METHODS
DNAs
pCITFA-7-PTP-NEO and the RNAi stem-loop vector
pCITFA-7-T7-stl were described previously (25). pCITFA-
7-eYFP-NEO was generated by inserting 353bp of the
CITFA-7 coding region (position 56 to position 408) into
the ApaI and NotI sites of pC-eYFP-NEO (26). pCITFA-
7-PTP-BLA was made by replacing the neomycin
phosphotransferase with the blasticidin S deaminase ORF,
pBLA-PTP-CITFA-2 and pBLA-PTP-RPB6z were likewise
generated from pPURO-PTP-CITFA-2 (24) and pPURO-
PTP-RPB6z (27). pPURO-mCherry-RPB6z was obtained
by replacing the sequence of the composite PTP tag
(protein C epitope, tobacco etch virus [TEV] protease site,
tandem protein A domain) with the mCherry fruit fluores-
cent protein coding region. Allele deletions were achieved by
transfecting polymerase chain reaction (PCR) products in
which 100bp of 50 and 30 gene flanks were fused to the
hygromycin phosphotransferase coding region. DNA oligo-
nucleotides that were used in competitive and quantitative
PCR (qPCR) are listed in Supplementary Table S1.
Semiquantitative reverse transcriptase-PCR (RT-PCR) was
performed using cycle numbers which were empirically
determined to be within the linear amplification range for
each oligonucleotide pair. To demonstrate that consensus
oligonucleotides co-amplify promoter sequences from differ-
ent BESs and RRNA repeats, we sequenced PCR amplifica-
tion products of genomic DNA and detected 11 out of 14
and 2 out of 3 known single-nucleotide polymorphisms of
BES (4) and RRNA promoters, respectively (Supplementary
Figure S1 and data not shown).
Cells
Culturing and stable transfection of BFs and PFs were
carried out as previously described (25,28). BF cells were
grown with either G418, puromycin, hygromycin,
phleomycin or blasticidin at final concentrations of 2.5,
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0.2, 1, 1 and 2 mg/ml, respectively, unless specified other-
wise. Double-strand CITFA-7 RNA expression was
induced with 2 mg/ml doxycycline. For in situ BES
switching, 1.8 104Np/nP cells were washed three times
with prewarmed medium, resuspended in medium to
2 103 cells/ml, divided into six aliquots and each
aliquot grown in antibiotic-free medium to a 13-ml
culture of 1 106 cells/ml. After dilution with an equal
volume of medium, cells were plated in 1ml aliquots of
either 10 mg/ml puromycin or 100 mg/ml G418. Stable
clonal cell lines were maintained at either 1 mg/ml puro-
mycin or 10 mg/ml G418. Assays of drug sensitivity of cells
following BES switchings were as described in (13),
namely, 10ml of 1 103 cells/ml were grown in either
1 mg/ml puromycin or 100 mg/ml G418 for 48 h, growth
was then monitored for 72 h.
Fluorescence microscopy
Microscope slides and coverslips (2.5 2.5 cm) were
washed in methanol in a heated ultrasonic water bath
for 20min, rinsed thoroughly with deionized water and
washed with 100% ethanol for 20min. Following a final
rinse in water, the slides and coverslips were air-dried.
A square chamber was made on each slide using strips
of labeling tape. Cells in exponential growth were
centrifuged for 4min at 800g and room temperature,
washed in cold medium and resuspended in cold BBSG
buffer (50mM Bicine, 77mM glucose, 50mM NaCl and
5mM KCl, pH 8.0) to a density of 1 105 cells/ml. Cells
were fixed by adding 4% paraformaldehyde to a final con-
centration of 0.05% for 1min after which they were
pelleted at 800g for 45 s. Following two washes with
BBSG buffer, the cell pellet was resuspended in BBSG
buffer to a final concentration of 4 105 cells/ml and 4,6-
diamidino-2-phenylindol (DAPI) was added to a final con-
centration of 0.04 mg/ml. Twenty-five microliters of cell
suspension were spread on the chamber and covered
with 125 ml of 1% low gelling agarose kept warm at
37C (Sigma, St. Louis, MO, USA), and a coverslip was
placed on top to close the chamber. Slides were stored at
4C for 16 h for complete cell fixation and pictures were
acquired within 24 h from the time of embedding, using an
Axiovert 200 microscope (Zeiss, Thornwood, NY, USA).
Images were processed with Axiovision software (Zeiss)
and ImageJ. Whole cell and ESB enhanced yellow fluor-
escent protein (eYFP) signals were quantified using
ImageJ and corrected by subtracting the mean pixel inten-
sity of the surrounding region of each cell analyzed.
Individual cell analysis was restricted to cells with only
one nucleus and one kinetoplast.
ChIP and ChIP-seq analyses
ChIP experiments were carried out as previously described
(29), resulting in average chromatin fragments of 200–
400 bp. Analysis of Np/nP cell lines required larger chro-
matin fragments to accommodate amplification of the se-
lectable marker regions downstream of the transcription
initiation site (TIS). DNA fragments of 600 bp were
obtained with medium sonication power using a
Bioruptor UCD-200 (Diagenode, New York, NY, USA)
and a reduced sonication time from 25 to 8min (30 s on/
30 s off). PTP-tagged CITFA-7, CITFA-2 and RPB6z
were immunoprecipitated with an anti-ProtA rabbit poly-
clonal serum (Sigma) and untagged RPA31 with a rat
anti-RPA31 immune serum (27). Negative control precipi-
tations were conducted with either rabbit or rat
nonspecific immune sera. The percent IP was calculated
relative to the input material and corrected by subtracting
the percent IP of the negative control assays. The fold
enrichment was obtained by dividing the amount of
precipitated DNA by the amount of DNA from control
precipitations. To generate the library for ChIP-seq
analysis, 1 109 cells were processed to produce 10 ng of
precipitated DNA. In this case, chromatin was sonicated
for 100min (ten 10min of 30 s on/30 s off with 5min
cooling on ice in between) on high setting to obtain
smaller fragments ranging from 100 to 250 bp in size.
qPCR quality controls and setup were analyzed as
described previously (29). For the preparation of ChIP-
seq libraries, 10 ng of input DNA and 10 ng of DNA
precipitated with CIFTA-7 were end-repaired by
incubating the DNA with 1T4 ligase buffer (NEB),
0.4mM dNTPs, 0.5 ml of End Repair Enzyme Mix
(NEB, 30 ml of 3U/ml T4 DNA polymerase, 6 ml of 1U/
ml Klenow Fragment, 30 ml of 10U/ml T4 DNA
Polynucleotide Kinase) in a total volume of 50 ml for
30min at 20C. The end-repaired DNA fragments were
cleaned up using AmPure XP beads (Beckman Coulter)
as suggested by Illumina. To generate a protruding 30A
base for adapter ligation, the end-repaired DNA was
mixed with 2 ml of 10NEB buffer 2, 1ml of 4mM
dATP and 0.5ml of Klenow 30 to 50 exo minus enzyme
(5U/ml, NEB) and incubated for 30min at 37C. Next,
the DNA was ligated to 1 ml of forked DNA adapters
(0.2 mM) using the Quick Ligation Kit (NEB) according
to the manufacturer’s specifications. To prepare the
forked adapters, forward (AATGATACGGCGACCAC
CGAGATCTACACTCTTTCCCTACACGACGCTCTT
CCGATC*T) and reverse DNA oligonucleotides (/5Phos/
GATCGGAAGAGCACACGTCTGAACTCCAGTCA
CGCCAATAT CTCGTATGCCGTCTTCTGCTT*G or/
5Phos/GATCGGAAGAGCACACGTCTGAACTCCA
GTCACCTT GTAATCTCGTATGCCGTCTTCTGCTT
*G) were suspended at 100 mM in 10mM Tris–HCl, pH
7.8, 0.1mM EDTA, pH 8.0, 50mM NaCl, mixed at equal
concentrations, heated to 95C and annealed by slowly
cooling the mix to room temperature (asterisk denotes a
phosphorothioate bond). Adaptor-annealed DNA was
cleaned up using AmPure XP beads and amplified using
the KAPA HIFI HotStart Ready Mix (Kapabiosystems)
and PCR primers 50-AATGATACGGCGACCACC
GA*G-30 (forward primer) and 50-CAAGCAGAAGAC
GGCATACGA*G-30 (reverse primer) for five cycles as
suggested by Kapabiosystems. The PCR product was
gel-purified and, again, PCR-amplified (15 cycles). The
final PCR product was cleaned up using the MinElute
PCR Purification Kit (Qiagen) and gel purified on a 1%
agarose gel followed by a cleanup using the MinElute Gel
extraction Kit (Qiagen). The quality and concentration of
the final libraries was determined using a BioAnalyzer
2100 (Agilent).
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Libraries from input and immunoprecipitated DNA were
sequenced using a HiSeq2000 sequencer (Illumina). For the
input DNA, we obtained 75167 347 sequence reads of
which 73.6% could be mapped (45.6% mapped to exactly
1 site). For the immunoprecipitated DNA, we obtained
16722 060 sequence reads of which 59.8% could be
mapped (39.8% mapped to exactly one site). The
sequence reads (100bp) were annotated based on the
T. brucei 427 genome (version 4.1) to which we added
the sequences of the 14 BESs available at http://www.
sanger.ac.uk/resources/downloads/protozoa/trypanosoma-
brucei.html. Standard and fast gapped read alignments
were performed using Bowtie version 2 (30). To normalize
the read coverage between the libraries, the read coverage
was divided by the total number of aligned reads in each
library and multiplied by the total number of aligned reads
of the smaller library.
RNA analysis
Total RNA was prepared by the hot phenol method
as specified previously (27). For pre-mRNA analysis,
total RNA was reverse transcribed with random
hexanucleotides (Roche) as primers and SuperScript II
reverse transcriptase (Invitrogen) following the manufac-
turer’s recommendations, and cDNA was amplified with
at least one oligonucleotide hybridizing outside the
sequence of the mature mRNA.
RESULTS
CITFA-7 occupancy of BES and RRNA promoters
To further investigate the transcriptional roles of the
CITFA complex in RNA pol I transcription, we
analyzed CITFA-7 occupancy of RRNA and BES pro-
moters in BFs. Previously, we have generated the BF
cell line TbC7ee that expresses CITFA-7 with a C-
terminal PTP tag and no untagged CITFA-7 (Figure 1)
(25). The large composite PTP tag which consists of a
protein C epitope, a TEV protease site and dual protein
A (ProtA) domains (31) did not affect the functionality of
CITFA-7 because CITFA-7 is essential for trypanosome
viability and TbC7ee cells proliferated as efficiently as
wild-type cells (25). Using a ChIP-grade, polyclonal anti-
ProtA antibody (32) and a nonspecific rabbit immune
serum for normalization, we precipitated chromatin
from TbC7ee cells. According to qPCR analysis using
consensus oligonucleotides for BES and for RRNA pro-
moters, both promoter sequences were clearly enriched in
the precipitate in comparison with the ba tubulin
intergenic region, which served as a negative control
(Figure 1). DNA fragments within the ESAG7 and 18S
rRNA coding regions, which extended to 1.6 and
1.2 kb downstream of the BES and RRNA TISs, respect-
ively, precipitated much less efficiently than their pro-
moters. Because we have previously found that RNA
pol I cross-linked equally to the RRNA promoter and to
the 18S rRNA coding region (29), these results strongly
indicated that CITFA-7 does not associate with
elongating RNA pol I and that it binds only to the
promoter region, thus substantiating the role of CITFA
as a transcription initiation factor. Most interestingly,
RRNA promoter DNA was consistently 5-fold more
enriched than BES promoter DNA. Because the trypano-
some harbors multiple copies of these promoters, this
result suggested that CITFA-7 occupied relatively more
RRNA than BES promoters and, therefore, raised the pos-
sibility that among BES promoters it primarily bound the
promoter of the active BES.
CITFA-7 predominantly occupies the active BES
promoter relative to a silent BES promoter
The previously described BF cell line PN13 in which the
silent BES1 and the active BES17 were marked with a
puromycin N-acetyltransferase gene (PUROR) and a
neomycin phosphotransferase (NEOR) gene, respectively
(13), was used to directly test the binding of CITFA-7 to
promoters of active and silent BESs. Both genes were
introduced at corresponding positions 240 bp downstream
Figure 1. CITFA-7 occupies specifically RNA pol I promoters. Top
panel, schematic drawing of the CITFA-7 locus in cell line TbC7ee,
which exclusively expresses CITFA-7 with a C-terminal PTP fusion.
The open reading frames of CITFA-7, of HYGR and NEOR, and the
PTP tag are indicated by an open box, striped boxes and a black box,
respectively. Smaller gray boxes represent gene flanks for RNA pro-
cessing signals. The PTP tag sequence was fused to an endogenous
CITFA-7 allele by targeted integration of pCITFA-7-PTP as indicated.
Bottom panel, anti-ProtA ChIP with TbC7ee cells expressing CITFA-7-
PTP. Precipitated DNA was analyzed by qPCR of the consensus BES
promoter (BES prom), a conserved region of the ESAG7 coding region
(ESAG7 ORF), the consensus RRNA promoter (RRNA prom), 18S
rRNA coding region (18S rDNA) and the b a tubulin intergenic
region (b a tub). The precipitation percentage relative to the input
material was corrected by subtracting corresponding values from
negative control precipitations that were carried out with a comparable
nonspecific antiserum.
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of the TIS, locations that allowed for the selection of in
situ switches between these two BESs and for specific
DNA amplification downstream of the BES1 and BES17
promoters. To enable anti-CITFA-7 ChIP experiments in
these cells, we stably integrated plasmid CITFA-7-PTP-
BLA into one CITFA-7 allele and termed the correspond-
ing line C7-Np1, indicating that these trypanosomes are
resistant to neomycin (upper case N), sensitive to puro-
mycin (lower case p) and represent the basal line from
which nP2 and Np3 cell lines were directly derived by con-
secutive in situ BES switching experiments (Figure 2A).
Anti-ProtA IP of chromatin prepared from C7-Np1
cells was first analyzed by a competitive PCR assay in
which a common sense primer was paired with two anti-
sense oligonucleotides that were complementary to either
the NEOR or the PUROR coding region (Figure 2A).
While the NEOR band was only slightly stronger than
the PUROR band in DNA isolated from total chromatin
or from the control IP, anti-CITFA-7 precipitated chro-
matin was strongly enriched in NEOR DNA derived from
the active BES17 (Figure 2B). Incubation of C7-Np1 cells
without antibiotics and subsequent selection with puro-
mycin combined with limiting dilution, revealed independ-
ent cell lines that had switched to the expression of BES1.
A corresponding ChIP analysis of one of these lines
(C7-nP2) showed that now the BES1-derived PUROR
band was highly enriched over the NEOR band,
demonstrating that high CITFA-7 occupancy correlated
with BES activation (Figure 2B).
To quantitatively assess CITFA-7 occupancy at BES1/
BES17 promoters in these cell lines, we carried out qPCR
analysis of precipitated DNA. To ensure specific amplifi-
cation of BES1 and BES17 sequences, we chose oligo-
nucleotide pairs that hybridized to the PUROR and
NEOR coding regions, respectively. As shown for the
original C7-Np1 cell line and six independently derived
C7-nP2 clones and C7-Np3 clones, CITFA-7 occupied
predominantly the active BES promoter relative to that
of the silenced BES (Figure 2C). This pattern was not
due to continuous selective antibiotic pressure because it
remained unchanged when the antibiotics were removed
for ten generations before the ChIP experiment. We did,
however, consistently detect above background levels of
CITFA-7 at the promoter of the silenced BES, indicating
that the transcription factor does interact with silent BES
promoters to some extent.
Although we specifically amplified the active BES in
these experiments, the precipitation percentage did not
increase over that of the assays of the consensus BES
promoter (compare Figure 2C with Figure 1). This has
two likely explanations: firstly, TbC7ee cells exclusively
expressed tagged CITFA-7, whereas C7-Np/nP lines co-
expressed wild-type and tagged CITFA-7. Secondly, in the
first experiment (Figure 1), we amplified the BES
promoter, which is the CITFA binding site, whereas the
specific NEOR and PUROR amplification products of the
subsequent experiment (Figure 2A) extended to positions
482 and 545 downstream of the TIS, respectively, thus
amplifying only a fraction of the precipitated DNA.
Accordingly, when we calculated the fold enrichment
over negative control precipitations, the active BES17 in
C7-Np1 cells exhibited a similarly high enrichment as the
consensus RRNA promoter, a nearly 8-fold higher enrich-
ment than that of the inactive BES1 promoter, and an
approximately four times higher enrichment than that of
the consensus BES promoter in TbC7ee cells, confirming
high CITFA-7 occupancy of the active BES promoter
(Figure 2D).
BES activation is regulated at the level of
transcription initiation
Our previous in vitro transcription results strongly
indicated that CITFA is a basal, DNA-binding transcrip-
tion initiation factor that mediates RNA pol I recruitment
to its cognate promoters. The purified CITFA complex
required both BES promoter elements for efficient DNA
binding and depletion of CITFA from extract resulted in
the loss of RRNA and BES promoter transcripts that were
only 127 and 146 nucleotides long, respectively (24;25).
Hence, high CITFA occupancy should lead to high
promoter-proximal transcription rates and to high RNA
pol I occupancy at the active BES promoter. To assess
promoter-proximal transcription levels at the active
versus the silenced BES, we quantified the abundances
of pre-NEOR and pre-PUROR mRNA relative to tubulin
pre-mRNA in C7-Np1 cells as well as in one C7-nP2 and
one C7-Np3 cell line (Figure 2E). Because in these cell
lines NEOR and PUROR RNA processing is directed by
aldolase gene flanks (13), we paired a sense oligonucleo-
tide that targets the aldolase 50 gene flank upstream of
the known aldolase splice site with either a NEOR- or
PUROR-specific antisense oligonucleotide to amplify
random hexamer-derived cDNA. As expected, pre-
mRNA of the selectable marker from the active site was
16 (Np1), 40 (nP2) and 24 (Np3) times more abundant
than tubulin pre-mRNA and exceeded the selectable
marker pre-mRNA from the inactive BES 59- to 79-fold
(Figure 2E).
Because this finding suggested a higher transcription
initiation rate from the active BES promoter than from
the inactive BES promoter, we wanted to determine the
promoter-proximal occupancy of RNA pol I at these sites.
We generated analogous to the C7-Np1 cell line
(Figure 2A), an R6z-Np1 cell line in which we introduced
the functional N-terminal PTP fusion (27) to the RNA pol
I-specific subunit RPB6z in PN13 cells. The corresponding
ChIP experiment demonstrated that RNA pol I occu-
pancy was 17-fold higher at the active BES17
promoter than at the silent BES1 promoter (Figure 2F).
Finally, we confirmed that CITFA-7 silencing is func-
tionally linked to the loss of promoter-proximal RNA pol
I occupancy and the reduced abundance of promoter-
proximal pre-RNA. Because BESs in our extant single
marker cells for gene knockdowns were unmarked, we
were unable to specifically investigate the active BES.
Instead, we focused our analysis on the RRNA promoter
region because CITFA-7 is equally important for RRNA
and BES transcription (25), and it is likely that mostRRNA
repeats are active in rapidly dividing, cultured trypano-
somes. For these ChIP experiments we used a polyclonal
antibody directed against the essential RNA pol I-specific
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subunit RPA31 (27). This antibody effectively precipitated
the RRNA promoter and the 18S rRNA coding region in
noninduced cells, while the ba tubulin intergenic region,
which is transcribed by RNA pol II, was not precipitated
above the control precipitation with a comparable nonspe-
cific polyclonal antibody (Figure 3A). On silencingCITFA-
7 for 42 h, RNA pol I occupancy decreased, on average, by
83% at the RRNA promoter and by 84% in the 18S rRNA
coding region. Similarly, promoter-proximal 18S pre-
rRNA abundances were reduced, on average, by 91.5%
in CITFA-7-silenced cells as analyzed by qPCR of
random hexamer-derived cDNA. The corresponding
semiquantitative qPCR analysis shows the drop of pre-
rRNA abundance and the concomitant increase of
tubulin pre-mRNA (Figure 3B). The latter finding is con-
sistent with our previous observation that the massive loss
of rRNA in CITFA-7-silenced cells led to an increase of all
nonaffected RNAs in total RNA preparations of equal
amounts (25). These results confirmed the pivotal role of
CITFA in RNA pol I transcription initiation.
Taken together, we have shown here that high CITFA-7
occupancy of the active BES promoter coincides with high
Figure 2. BES transcription is activated at the level of transcription initiation. (A) Schematic outline of genomic modifications in cell line C7-Np1 in
which NEOR and PUROR were inserted into the active BES17 and silent BES1, respectively, and the PTP sequence fused to the CITFA-7 coding
sequence in one CITFA-7 allele. Arrows labeled 1–3 represent primers used in the subsequent competitive PCR analysis. (B) Anti-CITFA-7-PTP
ChIP assays, carried out with C7-Np1 and one C7-nP2 cell line, in which BES1 was activated and BES17 silenced, were analyzed by competitive
PCR amplifying NEOR- and PUROR-specific sequences in total DNA (Inp), control IP (ctrl) and anti-ProtA IP (IP). (C) qPCR analysis of anti-
CITFA-7-PTP ChIP assays, carried out with clonal cell lines obtained from in situ switching events between BES17 and BES1, using NEOR- or
PUROR-specific primer pairs. The difference between BES17 and BES1 occupancies were statistically analyzed by paired two-tailed student’s t-tests.
One, two and three asterisks indicate P-values that are <0.05, 0.01 and 0.001, respectively. (D) Calculation of the fold enrichment over negative
control precipitations for the ChIP experiments shown in the bottom panel of Figure 1 and the C7-Np1 cell line shown in Figure 2C (BES17 NEOR
and BES1 PUROR). (E) Reverse transcription-qPCR analysis of NEOR or PUROR pre-mRNA abundances in C7-Np/nP cell lines. The values for
these relative abundances were standardized with the tubulin pre-mRNA level, which was set to 1. (F) qPCR analysis of anti-PTP-RPB6z ChIP with
R6z-Np1 cells. Results shown in (E) and (F) were statistically analyzed as described above.
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levels of promoter-proximal RNA from this BES and high
RNA pol I occupancy in the promoter region. In addition,
we demonstrated for the RRNA gene array that depletion
of CITFA-7 strongly reduces RNA pol I occupancy in
the promoter region and causes significant decreases of pro-
moter-proximal RNA abundance. Therefore, we concluded
that monoallelic BES transcription in T. brucei is regulated
at the level of transcription initiation.
BES promoter occupancy by CITFA-2 parallels that
of CITFA-7
The high occupancy of the active BES promoter by
CITFA-7 suggested that the whole CITFA complex is
bound there. To confirm this notion, we repeated the
ChIP analysis with the essential CITFA-2 subunit.
Similar to the CITFA-7 analysis, we generated cell line
C2-Np1 by tagging CITFA-2 N-terminally with PTP in
PN13 cells. We previously showed that PTP-CITFA-2 is
fully functional (24). The competitive PCR analysis
demonstrated even more strikingly than in the CITFA-7
analysis the predominant association of CITFA-2 with the
active BES promoter (Figure 4A). qPCR analyses of anti-
PTP-CITFA-2 ChIP assays conducted in C2-Np1 cells
and in independently derived, switched C2-nP2 and C2-
Np3 lines showed that CITFA-2 was even more distinctly
associated with the active BES than CITFA-7 (Figure 4B).
While in case of CITFA-7, on average 3.47 times more
DNA was precipitated from the active versus the silent
BES promoter, this fold difference in CITFA-2 occupancy
was, at 6.24, significantly higher (P=2.4 105, two-
tailed, unpaired student’s t-test assuming unequal
variance). Previously, by sedimenting tandem affinity-
purified CITFA complex through a linear sucrose
gradient, we obtained evidence that trypanosomes
possess two CITFA complexes: a more abundant
complex that lacks CITFA-2 and DYNLL1 and a
slightly faster sedimenting full complex (25). Because
CITFA-2 is indispensable for CITFA function in RNA
pol I transcription from BES, RRNA and GPEET
procyclin gene promoters, it appears that binding of
CITFA-2 to the complex activates CITFA. Therefore,
the more distinct association of CITFA-2 with the active
BES promoter may be directly related to the fact that
precipitating CITFA-2 specifically pulled down the
active CITFA complex. Together, these data strongly
indicated that, among BES promoters, CITFA is predom-
inantly bound to the active BES promoter.
Figure 3. CITFA-7 silencing affects RRNA promoter-proximal RNA pol I occupancy and pre-18S rRNA abundance. (A) Anti-RPA31 ChIP assays
were conducted with noninduced bloodstream trypanosomes (BFs) and with BFs in which CITFA-7 was silenced for 42 h. Precipitated chromatin was
analyzed by qPCR, amplifying regions of the RRNA promoter, the 18S rDNA and, as a control, the b a tubulin intergenic region. The experiments
were repeated three times and analyzed by an unpaired two-tailed Student’s t-test assuming unequal variances. (B) Semiquantitative RT-PCR
analysis of 18S pre-rRNA and tubulin pre-mRNA (pre-tub) in noninduced cells (n.i.) and CITFA-7-silenced cells.
Figure 4. High CITFA-2 occupancy of the active BES promoter.
(A) Anti-PTP-CITFA-2 ChIP assays with C2-Np1 and C2-nP2 cell
lines analyzed by competitive PCR of NEOR and PUROR sequences.
(B) Corresponding qPCR analysis of C2-Np/pN cell lines. Statistical
analysis was by paired two-tailed Student’s t-tests.
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CITFA-7 is concentrated in the nucleolus and the ESB
The efficiency of the RNA pol I transcription system is
due to its high initiation rate, which, as was shown for the
yeast ribosomal gene unit (33), can lead to an RNA pol I
density of one actively transcribing enzyme complex for
every 100 bp. Accordingly, detection of RNA pol I in the
ESB has been straightforward [reviewed in (34)]. On the
other hand, it was demonstrated in the human system that
the basal, promoter–binding RNA pol I transcription ini-
tiation factors SL1 and UBF can support multiple rounds
of transcription in vitro without dissociating from the
promoter (35), which suggests that relatively few tran-
scription factors are required to ensure maximal RNA
pol I transcription. Because the ESB appears to harbor a
single BES with either one or two BES promoters (4), it
was not certain whether CITFA would be detectable in
this compartment. However, in a previous study, when
we used indirect immunofluorescence microscopy to co-
localize the PTP-tagged RNA pol I subunit RPB6z and
HA-tagged CITFA-7, we occasionally detected a CITFA-
7 signal outside the nucleolus that co-localized with
RPB6z, suggesting that the ESB contains detectable
amounts of the transcription factor (25). To enhance the
sensitivity of the RPB6z/CITFA-7 co-localization, we
created a BF cell line in which, by targeted plasmid inte-
grations into the RPB6z and CITFA-7 loci, the mCherry
protein and the eYFP were N- and C-terminally fused
to RPB6z and CITFA-7, respectively (Figure 5A).
Fluorescence microscopy showed that in 39% of cells
(n=155) mCherry-RPB6z was detected only in the nucle-
olus, which is apparent in DAPI stains as a spherical
structure of low DNA density (Figure 5B, long arrow).
In 41% of cells, mCherry-RPB6z localized to the nucle-
olus as well as to a single extranucleolar spot that was
clearly separate from the nucleolus and, therefore, repre-
sented the ESB. Like the nucleolus, the ESB consistently
exhibited a reduced DAPI stain (Figure 5B, short
arrow). In the remaining 20% of cells, two extranucleolar
mCherry-RPB6z signals were detectable. These numbers
were in accordance with previous RNA pol I-based ESB
identifications (7,13). Although the nucleolar staining
patterns of CITFA-7-eYFP and mCherry-RPB6z were
not completely congruent, which could be expected from
a transcription initiation factor and an RNA pol, these
proteins exhibited extensive co-localization in the nucle-
olus of each cell analyzed. Most importantly, in 91% of
the cells with one or two extranucleolar spots, we could
detect co-localization of CITFA-7-eYFP in all these
spots (Figures 5B, C, two additional examples are shown
in Supplementary Figure S2A). Although after our
previous study we had anticipated that CITFA-7 would
be detectable in the ESB, the rather robust signal of
CITFA-7-eYFP in this compartment was nevertheless
surprising because it suggested a much larger accumula-
tion of the transcription factor in the ESB than is required
for RNA pol I transcription initiation from a single BES.
Quantification of eYFP fluorescence revealed that the ESB
signal contributed 4.5% to that of a whole cell (standard
deviation of 1.3%, n=10). Because an immunoblot
comparison of recombinant CITFA-7 with endogenous
CITFA-7 of whole cell lysates uncovered that a BF
trypanosome harbors 4000 CITFA-7 molecules
(Supplementary Figure S2B), we calculated that the ESB
contains 180 CITFA-7 molecules. Together, these data
show that CITFA-7 is concentrated in both the nucleolus
and the ESB, which strongly supports our finding of
predominant CITFA occupancy of the active BES
promoter.
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Figure 5. Co-localization of mCherry-RPB6z and CITFA-7-eYFP. (A)
Schematic of the RPB6z and CITFA-7 loci showing the targeted
pPURO-mCherry-RPB6z and pCITFA-7-eYFP-NEO integrations in
the BF cell line used here. (B) Images from top to bottom show
phase contrast, DAPI stain (bar: 10 mm; n, nucleus; k, kinetoplast;
long and short arrows indicate nucleolus and ESB, respectively),
mCherry-RPB6z, CITFA-7-eYFP (pseudo-colored in green) and an
image merge. Images on the left are unmodified, whereas red and
green signals in the enlarged images (panels in the middle and on the
right) were recolored and enhanced in brightness and contrast. (C)
Statistical analysis of 155 individual cells. Cells were categorized by
the number of extranucleolar RNA pol I (mCherry-RPB6z) spots.
Cells in which mCherry-RPB6z and CITFA-7-eYFP exhibited clear
co-localization in the nucleolus and all detectable extranucleolar spots
were scored as cells with complete co-localization.
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Peak(s) of CITFA-7 occupancy within a BES is
restricted to its promoter region(s)
Our findings of high CITFA occupancy of the active BES
promoter and the presence of 200 CITFA-7 molecules in
the ESB raised the question of how this factor is
concentrated in this compartment. We have previously
shown in vitro that the CITFA complex is a sequence-
specific DNA binding factor that requires both BES
promoter elements for efficient binding (24). However, it
was possible that BESs harbor multiple CITFA binding
sites or that CITFA-7 remains bound to RNA pol I during
transcription elongation, which would lead to an enrich-
ment of CITFA-7 along the entire BES. To determine the
presence of CITFA along the entire BES, we conducted
a genome-wide CITFA-7-PTP ChIP-seq analysis and
aligned the reads to the genome of T. brucei brucei 427
including the 14 BES sequences, which were available
for this strain (4). To account for sequencing biases and
alignment artifacts, the number of sequencing reads
obtained from the IP was normalized with the number
of sequencing reads obtained from the input material.
Reads (100 nt) were aligned to the most similar genomic
sequence or, if the target site was not unique, randomly
distributed among all possible target sites. Thus, the
analysis was limited by two constraints: firstly, BES
promoter regions are nearly identical, differing only in a
few single nucleotide polymorphisms, which made unam-
biguous alignment of most reads to particular BES pro-
moters impossible. Hence, reads from the active site were
presumably distributed among most BESs. Secondly, for
our analysis, we used cells that originated from the Tc221
clone of the 427 strain (36) that had switched expression
from the original VSG221 gene to an unknown VSG
gene (kind gift from Dr Peter Overath, MPI Tu¨bingen,
Germany). As we found out during our analysis, the
BES promoter regions of this strain differed in a few pos-
itions from the published 427 strain (4), preventing the
unambiguous identification of individual BESs according
to the known promoter sequences (data not shown).
Nevertheless, sequence reads could be aligned along all
BESs, indicating that the Tc221 BES sequences still
resembled the published ones enough to enable a mean-
ingful analysis.
Figure 6 shows the analysis of BES15 (also annotated as
telo126), which has two promoters of highly similar
sequence (P1 and P2). After normalizing for the different
number of reads obtained with input and immunopre-
cipitated DNA, peaks of reads were observed in several
BES regions, most of them in the 70-bp repeat regions,
the VSG gene and the VSG pseudogene (Figure 6, second
panel). However, these peaks were also observed in input
DNA that was not enriched by IP (Figure 6, third panel),
which suggests that they were formed owing to an
underrepresentation of these repetitive sequences in the pub-
lished genome. Two peaks in BES15, however, were absent
in the input. They precisely mapped to the two BES15 pro-
moters and, therefore, are the result of ChIP enrichment.
Accordingly, when we calculated the fold enrichment of
ChIP reads over input reads, 13.6- and 9.2-fold enrichments
were obtained for P1 and P2, respectively. Closer inspection
of the 67-bp-long P2 promoter showed that the highest
number of reads and the highest folds of enrichment pre-
cisely mapped to all seven windows representing the
promoter sequence (Figure 6, zoomed-in panels). The
number of reads on either side of the promoter rapidly
declined, suggesting that the transcription factor occupies
only the promoter and does not follow the polymerase
after transcription initiation. This notion was backed up
by our finding that RPA1, the largest subunit of RNA pol
I, did not co-immunoprecipitate with CITFA-7-PTP in a
DNA-independent manner (Supplementary Figure S3) and
by the fact that subunits of RNA pol I or of CITFA never
cross-purified in several tandem affinity purifications
(24,25,27,37,38). Hence, we concluded that, within a BES,
CITFA-7 occupancy is restricted to the promoter region
and that there are no additional binding sites that could
explain CITFA concentration in the ESB. This result is in
close agreement with our standard ChIP results, which
showed that CITFA-7 occupancy was strongly decreased
downstream of the BES promoter (Figure 1). Given that
the single 67-bp BES promoter is unlikely to support
binding of multiple CITFA complexes, and that CITFA is
not found away from this promoter, our data raise the inter-
esting possibility that CITFA is concentrated in the nucle-
olus and the ESB independent of DNA and RNA pol I
association, thereby restricting high RNA pol I transcrip-
tion initiation rates to these two compartments.
CITFA-7 was enriched to some extent on all BES pro-
moters analyzed (Supplementary Figure S4 and data not
shown). This likely resulted from reads of the active BES
being distributed among other BESs. In support of this
notion, we found more reads at RRNA promoters than on
BES promoters. Within the nine annotated RRNA pro-
moters, the peak window accumulated an average of
1233 normalized reads, which is 4.25-fold more than the
BES15 promoter peak, suggesting that reads from the
active BES were aligned to silent BESs owing to
sequence identities. Moreover, we observed several-fold
differences in the number of normalized reads assigned
to the different BES promoters that were phylogenetically
linked (Supplementary Figure S5). The combined reads
for the seven promoter windows ranged from 154 for the
single BES1 promoter to 2148 for the single BES5
promoter. Promoters whose sequence closely resembled
those of the similar BES15/BES5 promoters obtained
high numbers of reads, whereas more distantly related
BES promoters obtained much fewer reads. These
findings are in agreement with CITFA being predomin-
antly bound to the promoter of the active BES.
DISCUSSION
VSG expression in T. brucei is an ideal system to study the
mechanism of monoallelic gene expression because RNA
pol I transcription of the active BES in the ESB is spatially
separated from RRNA transcription in the nucleolus. We
took advantage of this fact and showed that CITFA-7, an
essential subunit of the CITFA complex, is concentrated
in the nucleolus and the ESB, substantially co-localizing
with RNA pol I in these compartments. Consistent with
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Figure 6. CITFA-7 enrichment at BES15 (telo126). For BES15, the fold enrichment of DNA immunoprecipitated with CITFA-7 compared with
input DNA (first panel) and the normalized read coverages obtained from the CITFA-7 IP (second panel) and the input material (third panel) are
shown. The read coverage was normalized to account for differences in library size (see ‘Materials and Methods’ section) and calculated for a
window size of 11 bp. Orange boxes represent ESAGs identified by numbers (e.g. seven stands for ESAG7) and of VSG genes ( identifies
pseudogenes), green boxes indicate promoters, and black boxes depict 70-bp repeats. For the zoomed-in panels, sequences for each window are
specified. The two BES promoter elements and the TIS position are identified by red lettering and the remaining promoter sequence by blue lettering.
The bars corresponding to the promoter sequence are depicted in blue. The green bar at the bottom represents the promoter region annotation in the
genome data bank.
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this observation, we found that CITFA-7 and the previ-
ously characterized, essential subunit CITFA-2 were pre-
dominantly associated with the promoter of the marked
active BES versus that of a marked silent BES. In situ
switching between these two BESs reversed the promoter
occupancy pattern of the two CITFA subunits, which es-
tablished that BES activation is coupled with high CITFA
interaction. Because CITFA is a promoter-binding tran-
scription initiation factor that is absolutely required for
RNA pol I transcription in vivo and in vitro (24,25), high
CITFA occupancy should lead to high rates of RNA pol I
recruitment and promoter-proximal transcription rates.
Accordingly, we found the RNA pol I-specific subunit
RPB6z to be highly abundant in the promoter region of
the active BES, and promoter-proximal RNA levels of the
active BES to exceed those of the silent BES 70-fold.
Furthermore, knockdown of CITFA-7 led to a sharp
decrease of RNA pol I occupancy at the RRNA
promoter and the downstream 18S RRNA coding
region, as well as a high reduction of the promoter-
proximal pre-rRNA. Together, these data show that
monoallelic VSG expression is controlled, at least par-
tially, at the level of transcription initiation and indicate
that this control is mediated by binding of a functional
CITFA complex to the active BES promoter. This is the
first demonstration in any system of antigenic variation
that basal transcription initiation factor occupancy
differs between the active and the silent genes.
Although CITFA predominantly occupied the active
BES promoter, we clearly observed above background
CITFA occupancy at the silent BES promoter. One pos-
sibility is that the marked silent BES in our study was not
completely silenced but remained in a ‘pre-active’ state.
Previously, as a model to explain co-expression of two
BESs under antibiotic selection, it was proposed that
between silent and active BESs there is a pre-active state
that precedes BES activation (39). The pre-active state of a
BES is characterized by close spatial proximity to the
active BES and thought to enable rapid back and forth
switching between these two BESs under selective
pressure. Because we switched repeatedly between BES1
and BES17, it is possible that the silenced BES was locked
in the pre-active state giving it greater access to CITFA
than a completely silenced BES. On the other hand, our
detection of CITFA at silent BES promoters is consistent
with previous studies demonstrating that a low level of
transcription does initiate at silent BESs but does not
reach the promoter-distal VSG gene (40,41). A previous
expression analysis of the promoter-proximal ESAG6 gene
revealed that 20% of all ESAG6 mRNA were derived
from silent BESs, whereas 80% originated from the active
site (40). Taking 15 BESs into account, this implies an
56-fold stronger transcription initiation rate from the
active BES than from any of the silent sites. This fold
difference closely reflects our pre-mRNA-based estimate
of an 70-fold higher initiation rate at the active BES
promoter. However, cloning and sequencing of RT-PCR
products along the complete BES revealed a more diverse
picture and promoter-proximal expression from silent
BESs varied strongly between different T. brucei strains
(41). Nevertheless, in all cases, promoter-proximal RNA
levels derived from the active BES did exceed those from
any silent BES manifold. Together, these results confirm
that activation of a BES not only requires ablation of
telomeric silencing but also a mechanism that leads to
higher transcription initiation rates.
Knowledge about proteins that preferentially interact
with the promoter regions of silenced or active BESs is
limited. While we do know that silent BESs are occupied
by nucleosomes that are absent from the active BES
(22,23), it is not known whether this difference is a conse-
quence of transcriptional activity or represents an actual
control mechanism (42). In agreement with the latter, a
recent study showed that the HMG (high mobility group)
box protein TDP1, which is thought to be a general archi-
tectural chromatin protein, exhibited high occupancy of
the active BES and RRNA gene units, thereby likely
facilitating their transcription (43). Additionally, histone
H1 (18) and NLP (17) were found to be mainly associated
with silent BES promoters, which suggest that they
have specific roles in reducing transcription from these
promoters. However, it remains unclear whether the dif-
ferential distributions of these proteins among BESs are
regulatory in nature or whether they reinforce the
activated or silenced status of a BES. Nevertheless, these
studies support our model that there are control mechan-
isms that operate at BES promoters.
Our data show that the active BES promoter recruits
CITFA more efficiently than a promoter of a silent BES.
One possible explanation for this difference is that repres-
sive chromatin interferes with CITFA binding to silent
BES promoters. This notion is supported by experiments
that showed that silencing of DAC3, ISWI and NLP led to
an upregulation in promoter-proximal gene expression at
silent BESs (14,16,17). However, in these cases the dere-
pressed expression level was not compared with that of the
active BES and it is likely that it remained considerably
lower. The high transcription level of the active BES (44)
likely impedes upregulation of all silent BESs to the same
level. If BES activation is achieved by derepression only,
one would expect that general BES derepression would
effectively impede transcription of the active site, owing
to competition for CITFA and RNA pol I. Thus far,
promoter-proximal transcription was only assessed in
the NLP knockdown, which led to a moderate 3-fold
reduction of mRNA from a selectable marker gene that
was introduced downstream of the active BES promoter
(17). Because our results suggest that the rate of RNA pol
I transcription initiation is limited by CITFA availability,
it will be important to analyze whether BES derepression
leads to higher CITFA occupancy.
An alternative explanation for the predominant associ-
ation of CITFA with the active BES would be a mechan-
ism that confines this basal transcription factor to the
nucleolus and the ESB, limiting its availability and high
RNA pol I transcription initiation rates to these compart-
ments. Because we did not find evidence for a direct inter-
action between CITFA-7 and RNA pol I and CITFA
appeared to be cross-linked only to the promoter region
in our ChIP-seq analysis, the high concentration of
CITFA-7 in these compartments seemed to be independ-
ent of RNA pol I and the capability of CITFA to bind
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DNA. A model of confined CITFA availability would be
in agreement with previous analyses of VSG expression.
The spatial proximity of co-expressed BESs observed by
Chaves et al. (39) could reflect the need to acquire CITFA
from the ESB for selectable marker expression. This
model would also be consistent with previous findings
showing that functional replacement of a BES promoter
with an RRNA promoter left BES regulation intact (45)
because CITFA also enables RRNA promoter transcrip-
tion (24). Finally, it concurs with results obtained on
silencing of RAP1, which led to a significant increase of
detectable RNA pol I accumulations outside the nucleolus
but did not alter the transcription efficiency of the
promoter-proximal BES regions (12). These findings
imply that transcription elongation of RNA pol I along
BESs is mainly blocked epigenetically and that, in accord-
ance with our results, VSG activation occurs at the BES
promoter region. Lastly, these results show that RNA pol
I accumulation at derepressed BESs is not sufficient to
drive promoter-proximal BES transcription, suggesting
that RNA pol I sequestration is not regulating BES tran-
scription, whereas confinement of CITFA may do so.
It should be noted here that CITFA subunits are
conserved among all trypanosomatids including those that
do not have a multifunctional RNA pol I. Except for some
structural differences between RRNA and BES promoters
(46), RRNA transcription initiation in the nucleolus and
BES transcription in the ESB appear to function equiva-
lently. Nevertheless, because protein sequestration to the
nucleolus is a well-established phenomenon (47), it is
possible that the ESB is a nucleolus-like structure that
offers interaction sites for the CITFA complex. As discussed
previously, the dynein component of CITFA is a likely can-
didate to facilitate factor sequestration (24). However,
DYNLL1 binding motifs, which are conserved from yeast
to mammals, were not detected in CITFA sequences and,
thus, will have to be determined experimentally.
Spatial confinement of an essential gene expression
factor may have relevance beyond T. brucei’s RNA pol I
system. In P. falciparum, the active var gene is transcribed
by RNA pol II in a perinuclear site and activation of
a silent var gene requires relocation from the hetero-
chromatic nuclear periphery to this euchromatic site
possibly to interact with a sequestered var gene-specific
transcription factor [reviewed in (9)]. Similarly, DNA
FISH analysis in the mouse system showed that the H
enhancer element co-localized with OR genes on dif-
ferent chromosomes, suggesting that nuclear positioning
of the active OR gene is important in this system as
well (48).
In summary, our results favor a bipartite model of
monoallelic VSG expression in which BES repression is
achieved epigenetically and the expressed BES is not only
derepressed by chromatin changes but also activated at the
promoter, a process that entails recruitment of CITFA.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We are grateful to Drs George Cross and Luisa
Figueiredo (Rockefeller University) for providing the
PN13 cell line and the BES switching protocol, to
Dr Ziyin Li (University of Texas, Houston) for construct
pC-eYFP-NEO, to Drs Ji Yu and Dongmyung Oh
(UConn Health Center) for help with fluorescence micros-
copy, to Ms Bao Nguyen for help with plasmid construc-
tion and to Dr Justin Radolf and Justin K. Kirkham for
critical reading of the manuscript.
FUNDING
This work was funded by the National Institutes of Health
grant [R01 AI059377 to A.G.]; the Young Investigator
Program of the Research Center of Infectious Diseases
(ZINF) of the University of Wu¨rzburg, Germany, and
the Human Frontier Science Program (to T.N.S.).
Funding for open access charge: National Institutes of
Health [R01 AI059377 to A.G.].
Conflict of interest statement. None declared.
REFERENCES
1. Horn,D. and McCulloch,R. (2010) Molecular mechanisms
underlying the control of antigenic variation in African
trypanosomes. Curr. Opin. Microbiol., 13, 700–705.
2. Magklara,A. and Lomvardas,S. (2013) Stochastic gene expression
in mammals: lessons from olfaction. Trends Cell Biol., 23,
449–456.
3. Schwede,A., Jones,N., Engstler,M. and Carrington,M. (2011) The
VSG C-terminal domain is inaccessible to antibodies on live
trypanosomes. Mol. Biochem. Parasitol., 175, 201–204.
4. Hertz–Fowler,C., Figueiredo,L.M., Quail,M.A., Becker,M.,
Jackson,A., Bason,N., Brooks,K., Churcher,C., Fahkro,S.,
Goodhead,I. et al. (2008) Telomeric expression sites are highly
conserved in Trypanosoma brucei. PLoS One, 3, e3527.
5. Gu¨nzl,A., Bruderer,T., Laufer,G., Schimanski,B., Tu,L.C.,
Chung,H.M., Lee,P.T. and Lee,M.G. (2003) RNA polymerase I
transcribes procyclin genes and variant surface glycoprotein gene
expression sites in Trypanosoma brucei. Eukaryot. Cell, 2,
542–551.
6. Chaves,I., Zomerdijk,J., Dirks,M.A., Dirks,R.W., Raap,A.K. and
Borst,P. (1998) Subnuclear localization of the active variant
surface glycoprotein gene expression site in Trypanosoma brucei.
Proc. Natl Acad. Sci. USA, 95, 12328–12333.
7. Navarro,M. and Gull,K. (2001) A pol I transcriptional body
associated with VSG mono-allelic expression in Trypanosoma
brucei. Nature, 414, 759–763.
8. Magklara,A., Yen,A., Colquitt,B.M., Clowney,E.J., Allen,W.,
Markenscoff-Papadimitriou,E., Evans,Z.A., Kheradpour,P.,
Mountoufaris,G., Carey,C. et al. (2011) An epigenetic signature
for monoallelic olfactory receptor expression. Cell, 145, 555–570.
9. Scherf,A., Lopez-Rubio,J.J. and Riviere,L. (2008) Antigenic
variation in Plasmodium falciparum. Annu. Rev. Microbiol., 62,
445–470.
10. Duraisingh,M.T., Voss,T.S., Marty,A.J., Duffy,M.F., Good,R.T.,
Thompson,J.K., Freitas-Junior,L.H., Scherf,A., Crabb,B.S. and
Cowman,A.F. (2005) Heterochromatin silencing and locus
repositioning linked to regulation of virulence genes in
Plasmodium falciparum. Cell, 121, 13–24.
11. Tonkin,C.J., Carret,C.K., Duraisingh,M.T., Voss,T.S., Ralph,S.A.,
Hommel,M., Duffy,M.F., Silva,L.M., Scherf,A., Ivens,A. et al.
(2009) Sir2 paralogues cooperate to regulate virulence genes and
antigenic variation in Plasmodium falciparum. PLoS Biol., 7, e84.
Nucleic Acids Research, 2014, Vol. 42, No. 5 3175
12. Yang,X., Figueiredo,L.M., Espinal,A., Okubo,E. and Li,B. (2009)
RAP1 is essential for silencing telomeric variant surface
glycoprotein genes in Trypanosoma brucei. Cell, 137, 99–109.
13. Figueiredo,L.M., Janzen,C.J. and Cross,G.A. (2008) A histone
methyltransferase modulates antigenic variation in African
trypanosomes. PLoS Biol., 6, e161.
14. Hughes,K., Wand,M., Foulston,L., Young,R., Harley,K.,
Terry,S., Ersfeld,K. and Rudenko,G. (2007) A novel ISWI is
involved in VSG expression site downregulation in African
trypanosomes. EMBO J., 26, 2400–2410.
15. Denninger,V., Fullbrook,A., Bessat,M., Ersfeld,K. and
Rudenko,G. (2010) The FACT subunit TbSpt16 is involved in
cell cycle specific control of VSG expression sites in Trypanosoma
brucei. Mol. Microbiol., 78, 459–474.
16. Wang,Q.P., Kawahara,T. and Horn,D. (2010) Histone
deacetylases play distinct roles in telomeric VSG expression site
silencing in African trypanosomes. Mol. Microbiol., 77,
1237–1245.
17. Narayanan,M.S., Kushwaha,M., Ersfeld,K., Fullbrook,A.,
Stanne,T.M. and Rudenko,G. (2011) NLP is a novel transcription
regulator involved in VSG expression site control in Trypanosoma
brucei. Nucleic Acids Res., 39, 2018–2031.
18. Povelones,M.L., Gluenz,E., Dembek,M., Gull,K. and Rudenko,G.
(2012) Histone H1 plays a role in heterochromatin formation and
VSG expression site silencing in Trypanosoma brucei. PLoS
Pathog., 8, e1003010.
19. Tiengwe,C., Marcello,L., Farr,H., Dickens,N., Kelly,S.,
Swiderski,M., Vaughan,D., Gull,K., Barry,J.D., Bell,S.D. et al.
(2012) Genome-wide analysis reveals extensive functional
interaction between DNA replication initiation and transcription
in the genome of Trypanosoma brucei. Cell Rep., 2, 185–197.
20. Alsford,S. and Horn,D. (2012) Cell-cycle-regulated control of
VSG expression site silencing by histones and histone chaperones
ASF1A and CAF-1b in Trypanosoma brucei. Nucleic Acids Res.,
40, 10150–10160.
21. Kim,H.S., Park,S.H., Gu¨nzl,A. and Cross,G.A. (2013) MCM-BP
is required for repression of life-cycle specific genes transcribed by
RNA polymerase I in the mammalian infectious form of
Trypanosoma brucei. PLoS One, 8, e57001.
22. Figueiredo,L.M. and Cross,G.A. (2010) Nucleosomes are depleted
at the VSG expression site transcribed by RNA polymerase I in
African trypanosomes. Eukaryot. Cell, 9, 148–154.
23. Stanne,T.M. and Rudenko,G. (2010) Active VSG expression sites
in Trypanosoma brucei are depleted of nucleosomes. Eukaryot.
Cell, 9, 136–147.
24. Brandenburg,J., Schimanski,B., Nogoceke,E., Nguyen,T.N.,
Padovan,J.C., Chait,B.T., Cross,G.A. and Gu¨nzl,A. (2007)
Multifunctional class I transcription in Trypanosoma brucei
depends on a novel protein complex. EMBO J., 26, 4856–4866.
25. Nguyen,T.N., Nguyen,B.N., Lee,J.H., Panigrahi,A.K. and
Gu¨nzl,A. (2012) Characterization of a novel class I transcription
factor A (CITFA) subunit that is indispensable for transcription
by the multifunctional RNA polymerase I of Trypanosoma brucei.
Eukaryot. Cell, 11, 1573–1581.
26. Li,Z., Umeyama,T. and Wang,C.C. (2009) The Aurora Kinase in
Trypanosoma brucei plays distinctive roles in metaphase-anaphase
transition and cytokinetic initiation. PLoS Pathog., 5, e1000575.
27. Nguyen,T.N., Schimanski,B. and Gu¨nzl,A. (2007) Active RNA
polymerase I of Trypanosoma brucei harbors a novel subunit
essential for transcription. Mol. Cell. Biol., 27, 6254–6263.
28. Laufer,G., Schaaf,G., Bollgo¨nn,S. and Gu¨nzl,A. (1999) In vitro
analysis of alpha-amanitin-resistant transcription from the rRNA,
procyclic acidic repetitive protein, and variant surface
glycoprotein gene promoters in Trypanosoma brucei. Mol. Cell.
Biol., 19, 5466–5473.
29. Park,S.H., Nguyen,T.N., Kirkham,J.K., Lee,J.H. and Gu¨nzl,A.
(2011) Transcription by the multifunctional RNA polymerase I in
Trypanosoma brucei functions independently of RPB7. Mol.
Biochem. Parasitol., 180, 35–42.
30. Langmead,B. and Salzberg,S.L. (2012) Fast gapped-read
alignment with Bowtie 2. Nat. Methods, 9, 357–359.
31. Schimanski,B., Nguyen,T.N. and Gu¨nzl,A. (2005) Highly efficient
tandem affinity purification of trypanosome protein complexes
based on a novel epitope combination. Eukaryotic Cell, 4,
1942–1950.
32. Lee,J.H., Cai,G., Panigrahi,A.K., Dunham-Ems,S., Nguyen,T.N.,
Radolf,J.D., Asturias,F.J. and Gu¨nzl,A. (2010) A TFIIH-
associated mediator head is a basal factor of small nuclear spliced
leader RNA gene transcription in early-diverged trypanosomes.
Mol. Cell. Biol., 30, 5502–5513.
33. French,S.L., Osheim,Y.N., Cioci,F., Nomura,M. and Beyer,A.L.
(2003) In exponentially growing Saccharomyces cerevisiae cells,
rRNA synthesis is determined by the summed RNA polymerase I
loading rate rather than by the number of active genes. Mol. Cell
Biol., 23, 1558–1568.
34. Navarro,M., Penate,X. and Landeira,D. (2007) Nuclear
architecture underlying gene expression in Trypanosoma brucei.
Trends Microbiol., 15, 263–270.
35. Panov,K.I., Friedrich,J.K. and Zomerdijk,J.C. (2001) A step
subsequent to preinitiation complex assembly at the ribosomal
RNA gene promoter is rate limiting for human RNA
polymerase I-dependent transcription. Mol. Cell Biol., 21,
2641–2649.
36. Hirumi,H., Hirumi,K., Doyle,J.J. and Cross,G.A. (1980) In vitro
cloning of animal-infective bloodstream forms of Trypanosoma
brucei. Parasitology, 80, 371–382.
37. Nguyen,T.N., Schimanski,B., Zahn,A., Klumpp,B. and Gu¨nzl,A.
(2006) Purification of an eight subunit RNA polymerase I
complex in Trypanosoma brucei. Mol. Biochem. Parasitol., 149,
27–37.
38. Walgraffe,D., Devaux,S., Lecordier,L., Dierick,J.F., Dieu,M., Van
Den,A.J., Pays,E. and Vanhamme,L. (2005) Characterization of
subunits of the RNA polymerase I complex in Trypanosoma
brucei. Mol. Biochem. Parasitol., 139, 249–260.
39. Chaves,I., Rudenko,G., Dirks,M.A., Cross,M. and Borst,P. (1999)
Control of variant surface glycoprotein gene-expression sites in
Trypanosoma brucei. EMBO J., 18, 4846–4855.
40. Ansorge,I., Steverding,D., Melville,S., Hartmann,C. and
Clayton,C. (1999) Transcription of ‘inactive’ expression sites in
African trypanosomes leads to expression of multiple transferrin
receptor RNAs in bloodstream forms. Mol. Biochem. Parasitol.,
101, 81–94.
41. Vanhamme,L., Poelvoorde,P., Pays,A., Tebabi,P., Xong,H.V. and
Pays,E. (2000) Differential RNA elongation controls the variant
surface glycoprotein gene expression sites of Trypanosoma brucei.
Mol. Microbiol., 36, 328–340.
42. Rudenko,G. (2010) Epigenetics and transcriptional control in
African trypanosomes. Essays Biochem., 48, 201–219.
43. Narayanan,M.S. and Rudenko,G. (2013) TDP1 is an HMG
chromatin protein facilitating RNA polymerase I transcription in
African trypanosomes. Nucleic Acids Res., 41, 2981–2992.
44. Ehlers,B., Czichos,J. and Overath,P. (1987) RNA turnover in
Trypanosoma brucei. Mol. Cell Biol., 7, 1242–1249.
45. Rudenko,G., Blundell,P.A., Dirks Mulder,A., Kieft,R. and
Borst,P. (1995) A ribosomal DNA promoter replacing the
promoter of a telomeric VSG gene expression site can be
efficiently switched on and off in T. brucei. Cell, 83, 547–553.
46. Gu¨nzl,A., Vanhamme,L. and Myler,P.J. (2007) Transcription in
trypanosomes: a different means to the end. In: Barry,J.D.,
Mottram,J.C., McCulloch,R. and Acosta-Serrano,A. (eds),
Trypanosomes—After the Genome. Horizon Press, Pittsburgh,
pp. 177–208.
47. Emmott,E. and Hiscox,J.A. (2009) Nucleolar targeting: the hub
of the matter. EMBO Rep., 10, 231–238.
48. Lomvardas,S., Barnea,G., Pisapia,D.J., Mendelsohn,M.,
Kirkland,J. and Axel,R. (2006) Interchromosomal interactions
and olfactory receptor choice. Cell, 126, 403–413.
3176 Nucleic Acids Research, 2014, Vol. 42, No. 5
